---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-012294"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T10:46:21.291727+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics raises executive base salaries, grants FY2024 bonuses and equity awards

## Summary
- CEO Bhatnagar base salary increased to $739,000 effective Jan 1, 2025; FY2024 cash bonus of $403,200.
- CFO Mackaness base salary set at $511,000; FY2024 bonus of $193,200; 31,000 options and 14,500 RSUs awarded.
- SVP Hirano base salary $432,000; FY2024 bonus $137,812; 13,800 options and 6,400 RSUs awarded.
- Options vest over 4 years (monthly after 1-year cliff); RSUs vest 25% per year over 4 years.

## SEC filing metadata
- accession: 0001193125-25-012294
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312525012294/0001193125-25-012294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312525012294/d913677d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-012294
- JSON: https://secwatch.observer/filing/0001193125-25-012294.json
- Plain text: https://secwatch.observer/filing/0001193125-25-012294.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.